Table 1 HPV prevalence detected by the RT hrHPV test and the HC2 test in comparison to the liquid based cytology (LBC) results
LBC | RT + ve % (95 % CI) | HR HC2 + ve % (95 % CI) | κ (95 % CI) |
|---|---|---|---|
Normal (Pap I/II) | 5.4 % (4.2-6.9) | 5.6 % (4.3-7.1) | 0.78 (0.69-0.87) |
ASC-US (Pap IIw) | 21.4 % (12.7-33.8) | 28.6 % (18.4-41.5) | 0.62 (0.38-0.86) |
ASC-H, AGC (Pap III) | 50.0 % (28.0–72.0) | 50.0 % (28.0–72.0) | 1 (1.0–1.0) |
LSIL, HSIL (Pap IIID) | 65.1 % (59.6–70.3) | 72.1 % (66.8–76.9) | 0.76 (0.68–0.84) |
HSIL, CIS (Pap IVa) | 94.7 % (82.7–98.6) | 100 % (90.8–100) | 1 |
HSIL, CIS, Micro (IVb) | 100 % (34.2–100) | 100 % (34.2–100) | 1 |
Micro, Invasive (PapV) | 100 % (20.6–100) | 100 % (20.6–100) | 1 |
HSIL+ (≥Pap IVa) | 95.1 % (83.9–98.7) | 100 % (91.4–100) | 1 |
AGC+ (≥Pap III) | 68.0 % (62.9–72.5) | 74.3 % (69.5–78.6) | 0.78 (0.70–0.84) |
Overall | 21.4 % (19.3–23.5) | 23.4 % (21.3–25.6) | 0.87 (0.84–0.90) |